An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Príomhchruthaitheoir: | Bristy, Israt Zerin |
---|---|
Rannpháirtithe: | Kabir, Md. Tanvir |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2021
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/15619 |
Míreanna comhchosúla
-
Molecules associated with the development of lung cancer
de réir: Rahman, Adree, et al.
Foilsithe / Cruthaithe: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
de réir: Shabnam, Musharrat
Foilsithe / Cruthaithe: (2018) -
Immunotherapy in the Management of Lung Cancer
de réir: Tasnim, Humayra
Foilsithe / Cruthaithe: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
de réir: Paul, Pulock
Foilsithe / Cruthaithe: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
de réir: Mim, Shanzida
Foilsithe / Cruthaithe: (2023)